Goldman Sachs Maintains Buy on Merck & Co, Raises Price Target to $160

Benzinga Newsdesk www.benzinga.com Positive 80.8%

Neg 0% Neu 0% Pos 80.8%

Goldman Sachs analyst Terence Flynn maintains Merck & Co (NYSE:MRK) with a Buy and raises the price target from $140 to $160.